THE validity of diagnoses of childhood Attention Deficit Hyperactivity Disorder (ADHD) has been called into question with the release of a number of studies revealing that the youngest children in a school class are more likely than their classmates to receive pharmacological treatment for the disorder.
Four international studies and now a new Australian study investigating Western Australian children have confirmed the trend.
Age-related learning readiness has long been suspected as an influencing factor and the research has implications for parents and schools around school starting ages, especially for boys who outnumber girls significantly.
CLICK HERE for the MJA paper.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Jan 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Jan 17
